In this issue:
- Antithrombotics for outpatients with stable symptomatic COVID-19
- Few symptomatic thrombotic events in hospitalised adults with COVID-19
- Mycophenolate mofetil for first-line treatment of ITP
- ICH after head injury among older patients on anticoagulants
- Management of single subsegmental PE
- Management strategies and clinical outcomes of IVC thrombosis
- Predictors of fibrotic progression in essential thrombocythaemia
- VTE recurrence among extended oral anticoagulant recipients for a first unprovoked VTE
- Tretinoin + high-dose dexamethasone, first-line, for newly diagnosed ITP
- 2 weeks of LMWH for isolated distal DVT
Please login below to download this issue (PDF)